Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Global industry leaders to address key trends in bioscience industry at Biotech 2009

Biotech 2009 (www.biotech2009.org) will bring together globally-recognized industry leaders to address key trends and topics relevant to the growth and advancement of the tri-state region’s bioscience industry.

13 Nov 2009

Shire announces findings from Phase 3 study data with Vyvanse

Shire plc, the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.

13 Nov 2009

Memphis Mayor supports new program that assists individuals with bipolar disorder

On November 17 at 2:00 pm, Memphis Mayor AC Wharton will announce during a press conference at the University of Tennessee Health Science Center his support for the a new cooperative venture that assists individuals with bipolar disorder.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

Oxytocin hormone affects behaviors, finds new study

A new study carried out at the University of Haifa has found that oxytocin, also known as the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating.

12 Nov 2009

Memphis Mayor supports National Bipolar Foundation; sees benefit in preventative care program

Memphis Mayor, A.C. Wharton stands up for the outstanding Memphis-based National Bipolar Foundation; a press conference is to be hosted by University of Tennessee Health & Science Center on November 17th at 2pm at the Student Center at 800 Madison in Room 305.

12 Nov 2009

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.

11 Nov 2009

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced the re-launch of FOCUS (http://www.vyvanseFOCUS.com), a free, online patient support program for adults taking once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), and the only online, branded personalized patient support program providing tips and tools for adults diagnosed with ADHD taking a prescription medication.

11 Nov 2009

Potential benefits of Labopharm's novel trazodone formulation published

Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.

11 Nov 2009

Women face higher risk of post-stroke depression

Depression occurs in as many as one-third of patients after a stroke, and women are at somewhat higher risk, according to a large new review of studies. Post-stroke depression is associated with greater disability, reduced quality of life and an increased risk of death.

11 Nov 2009

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Academic Health Center scientists, physicians, and research centers have attracted 128 grants totaling nearly $35 million in federal stimulus money (as of Nov. 10) since the American Recovery and Reinvestment Act was approved in February 2009. This will result in a total economic impact of more than $105 million; according to the National Institutes of Health, $1 of research funding multiplies to more than $2 of goods and services in the economy.

11 Nov 2009

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Catalyst Pharmaceutical Partners, Inc. today reported that a team of neuroscientists at The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System (LIJ) has received a $1.2 million grant from the U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate addiction.

10 Nov 2009

Recollections of traumatic incidents can be controlled

It is well known that fear memories are permanent. However, a recent paper in Science, evaluated by three Faculty Members for F1000, reports an extraordinary finding that supports the use of a drug to control recollections of traumatic incidents.

10 Nov 2009

Geisinger launches RRVI for rural veterans and their families

Veteran's Day has a new meaning for a Geisinger team of clinicians and researchers who recently launched the Reaching Rural Veterans Initiative (RRVI). Utilizing financial grants from the Commonwealth of Pennsylvania and the Health Resources and Services Administration, the team is focused on developing a model to improve the way healthcare providers identify and care for combat stress-related injuries in returning veterans and their families.

9 Nov 2009

Shire's INTUNIV for treating ADHD now available in the U.S.

Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.

9 Nov 2009

$Connection between depression and loss of bone mass leads to osteoporosis and fractures$

Connection between depression and loss of bone mass leads to osteoporosis and fractures

Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures.

9 Nov 2009

Study finds brain changes and severe depression in political detainees experiencing head injury

Depression and other emotional symptoms in survivors of torture and other traumatic experiences may be exacerbated by the effects of head injuries, according to a study from the Harvard Program in Refugee Trauma (HPRT), based in the Massachusetts General Hospital (MGH) Department of Psychiatry.

7 Nov 2009

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility.

6 Nov 2009

Rush University Medical Center opens TMS Clinic to offer non-drug treatment for depression

Rush University Medical Center has opened the Transcranial Magnetic Stimulation (TMS) Clinic to offer patients suffering from major depression a safe, effective, non-drug treatment. TMS therapy is the first FDA-approved, non-invasive antidepressant device-based treatment clinically proven for treatment of depression.

6 Nov 2009

Comparative study reveals similar brain networks in human and monkey brains

A study published this week in PNAS provides a comprehensive comparative functional anatomy study in human and monkey brains which reveals highly similar brain networks preserved across evolution.

4 Nov 2009

Psychiatry News and Research

Further Reading

Global industry leaders to address key trends in bioscience industry at Biotech 2009

Shire announces findings from Phase 3 study data with Vyvanse

Memphis Mayor supports new program that assists individuals with bipolar disorder

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

Oxytocin hormone affects behaviors, finds new study

Memphis Mayor supports National Bipolar Foundation; sees benefit in preventative care program

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Potential benefits of Labopharm's novel trazodone formulation published

Women face higher risk of post-stroke depression

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Recollections of traumatic incidents can be controlled

Geisinger launches RRVI for rural veterans and their families

Shire's INTUNIV for treating ADHD now available in the U.S.

Connection between depression and loss of bone mass leads to osteoporosis and fractures

Study finds brain changes and severe depression in political detainees experiencing head injury

Boosting NAD+ after spinal cord injury may prevent permanent nerve death

Rush University Medical Center opens TMS Clinic to offer non-drug treatment for depression

Comparative study reveals similar brain networks in human and monkey brains

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News